Oruka Therapeutics (ORKA) Prepaid Assets (2010 - 2026)
Oruka Therapeutics (ORKA) recorded quarterly Prepaid Assets of $6.4 million in Q1 2026, down 5.77% quarter-over-quarter from $6.8 million in Q4 2025, and up 114.79% on a YoY basis from $3.0 million in Q1 2025.
Oruka Therapeutics (ORKA) Prepaid Assets (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 114.79% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 114.79% YoY), while the FY2025 annual figure was $6.8 million, up 457.99% from the prior year.
- Prepaid Assets was $6.4 million for Q1 2026 at Oruka Therapeutics, down from $6.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.8 million in Q4 2025 to a low of $161000.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $2.1 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets tumbled 76.08% in 2022, then surged 658.39% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $254000.0 in 2022, then sank by 36.61% to $161000.0 in 2023, then soared by 658.39% to $1.2 million in 2024, then soared by 457.99% to $6.8 million in 2025, then dropped by 5.77% to $6.4 million in 2026.
- The last three Prepaid Assets figures came in at $6.4 million (Q1 2026), $6.8 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 6.01 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 537,000.00 |
| Mar 31, 2024 | 767,000.00 |
| Dec 31, 2023 | 161,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 599,000.00 |
| Mar 31, 2023 | 852,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 611,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 1.60 Mn |